Delta-Fly Pharm
Delta-Fly Pharma develops new, affordable anticancer drugs with improved safety and efficacy using existing compounds, aiming to reduce side effects and alleviate the economic burden on patients and governments. Learn more
Launch date
Employees
Market cap
CAD47.6m
Enterprise valuation
CAD39m (Public information from Sep 2024)
Share price
JPY558 4598.T
Tokushima-Shi Tokushima Prefecture (HQ)
Authorizing premium user...